Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 End stage renal disease industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Treatment trends
2.5 Diagnosis trends
2.6 End-use trends
Chapter 3 End Stage Renal Disease Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
3.2.1.2 Technological advancement in diagnostic and treatment devices
3.2.1.3 Increasing prevalence of diabetes and hypertension
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of equipments
3.2.2.2 Complications associated with the treatment of ESRD
3.3 Growth potential analysis
3.3.1 By treatment
3.3.2 By diagnosis
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 End Stage Renal Disease Market Size and Forecast, By Treatment (USD Million)
5.1 Key trends, by treatment
5.2 Transplant
5.3 Dialysis
5.3.1 Hemodialysis
5.3.2 Peritoneal Dialysis
Chapter 6 End Stage Renal Disease Market Size and Forecast, By Diagnosis (USD Million)
6.1 Key trends, by diagnosis
6.2 Blood Test
6.3 Urine Test
6.4 Imaging Test
6.5 Others
Chapter 7 End Stage Renal Disease Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Dialysis centers
7.4 Others
Chapter 8 End Stage Renal Disease Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Sweden
8.3.7 Poland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Philippines
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 AngioDynamics, Inc.
9.2 Asahi Kasei Medical Co., Ltd.
9.3 B. Braun Melsungen AG
9.4 Baxter International, Inc.
9.5 Becton Dickinson and Company
9.6 Cantel Medical
9.7 DaVita Inc.
9.8 Fresenius Medical Care AG & Co. KGaA
9.9 JMS Co. Ltd.
9.10 Medtronic Plc
9.11 Nikkiso Co., Ltd.
9.12 Nipro Corporation
9.13 Teleflex Incorporated
9.14 Toray Industries Inc.
9.15 U.S. Renal Care, Inc.
